Basma Adeem Medical Co. (9626.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Basma Adeem Medical Co., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | 13.83x | 18.16x | 23.49x | 30.24x |
| P/B Ratio | 0.00x | 5.13x | 11.67x | 23.16x |
| P/S Ratio | 2.22x | 3.37x | 4.31x | 5.22x |
| Profitability | ||||
| Gross Margin | 29.3% | 88.1% | 30.4% | 31.0% |
| Operating Margin | 17.8% | 76.2% | 20.8% | 20.1% |
| Net Margin | 16.1% | 18.6% | 18.4% | 17.3% |
| EBITDA Margin | 17.8% | 79.9% | 25.9% | 23.6% |
| Liquidity | ||||
| Current Ratio | 0.00x | 5.21x | 2.76x | 1.90x |
| Quick Ratio | 0.00x | 4.94x | 2.59x | 1.86x |
| Leverage | ||||
| Debt/Equity | 0.00x | 0.53x | 0.45x | 1.04x |
YoY = year-over-year change. Source: FMP..